Review



primary antibodies targeting ccl4  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Bioss primary antibodies targeting ccl4
    Candidate Drug Predicted Using DSigDB
    Primary Antibodies Targeting Ccl4, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies targeting ccl4/product/Bioss
    Average 94 stars, based on 4 article reviews
    primary antibodies targeting ccl4 - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration"

    Article Title: Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration

    Journal: Journal of Inflammation Research

    doi: 10.2147/JIR.S500214

    Candidate Drug Predicted Using DSigDB
    Figure Legend Snippet: Candidate Drug Predicted Using DSigDB

    Techniques Used:

    Docking Results of Available Proteins With Candidate Drugs
    Figure Legend Snippet: Docking Results of Available Proteins With Candidate Drugs

    Techniques Used: Binding Assay

    Molecular docking simulation diagram. ( A ) (+)-chelidonine binds to CCL4. ( B ) oxazolone binds to CCL4. ( C ) eugenol binds to CCL4. ( D ) simvastatin binds to CCL4. ( E ) (+)-chelidonine binds to FCGR2B. ( F ) oxazolone binds to FCGR2B. ( G ) eugenol binds to FCGR2B. ( H ) AGN-PC-0JHFVD binds to FCGR2B. ( I ) AGN-PC-0JHFVD binds to FOXP3. ( J ) simvastatin binds to FOXP3. CCL4 is marked in red, FCGR2B in wheat, FOXP3 in green, and candidate drugs in cyan. Blue solid lines represent hydrogen bonds, grey dotted lines represent hydrophobic interactions, and green dotted lines represent π-stacking interactions.
    Figure Legend Snippet: Molecular docking simulation diagram. ( A ) (+)-chelidonine binds to CCL4. ( B ) oxazolone binds to CCL4. ( C ) eugenol binds to CCL4. ( D ) simvastatin binds to CCL4. ( E ) (+)-chelidonine binds to FCGR2B. ( F ) oxazolone binds to FCGR2B. ( G ) eugenol binds to FCGR2B. ( H ) AGN-PC-0JHFVD binds to FCGR2B. ( I ) AGN-PC-0JHFVD binds to FOXP3. ( J ) simvastatin binds to FOXP3. CCL4 is marked in red, FCGR2B in wheat, FOXP3 in green, and candidate drugs in cyan. Blue solid lines represent hydrogen bonds, grey dotted lines represent hydrophobic interactions, and green dotted lines represent π-stacking interactions.

    Techniques Used:

    External validation of CCL4 and FCGR2B. ( A ) The mRNA levels of CCL4 and FCGR2B were evaluated in animal models by RT-qPCR. ( B ) The protein levels of CCL4 and FCGR2B were evaluated animal models by WB. ** represents P <0.01, * represents P <0.05 and ns, no significance.
    Figure Legend Snippet: External validation of CCL4 and FCGR2B. ( A ) The mRNA levels of CCL4 and FCGR2B were evaluated in animal models by RT-qPCR. ( B ) The protein levels of CCL4 and FCGR2B were evaluated animal models by WB. ** represents P <0.01, * represents P <0.05 and ns, no significance.

    Techniques Used: Quantitative RT-PCR



    Similar Products

    primary antibodies targeting ccl4  (Bioss)
    94
    Bioss primary antibodies targeting ccl4
    Candidate Drug Predicted Using DSigDB
    Primary Antibodies Targeting Ccl4, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies targeting ccl4/product/Bioss
    Average 94 stars, based on 1 article reviews
    primary antibodies targeting ccl4 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Candidate Drug Predicted Using DSigDB

    Journal: Journal of Inflammation Research

    Article Title: Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration

    doi: 10.2147/JIR.S500214

    Figure Lengend Snippet: Candidate Drug Predicted Using DSigDB

    Article Snippet: Primary antibodies targeting CCL4 (1:1000, Bioss, bs-2475R, China), FCGR2B (1:1000, Abclonal, A12553, China) and β-actin (1:1000, ZSGB-BIO, TA-09, China) overnight at 4°C.

    Techniques:

    Docking Results of Available Proteins With Candidate Drugs

    Journal: Journal of Inflammation Research

    Article Title: Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration

    doi: 10.2147/JIR.S500214

    Figure Lengend Snippet: Docking Results of Available Proteins With Candidate Drugs

    Article Snippet: Primary antibodies targeting CCL4 (1:1000, Bioss, bs-2475R, China), FCGR2B (1:1000, Abclonal, A12553, China) and β-actin (1:1000, ZSGB-BIO, TA-09, China) overnight at 4°C.

    Techniques: Binding Assay

    Molecular docking simulation diagram. ( A ) (+)-chelidonine binds to CCL4. ( B ) oxazolone binds to CCL4. ( C ) eugenol binds to CCL4. ( D ) simvastatin binds to CCL4. ( E ) (+)-chelidonine binds to FCGR2B. ( F ) oxazolone binds to FCGR2B. ( G ) eugenol binds to FCGR2B. ( H ) AGN-PC-0JHFVD binds to FCGR2B. ( I ) AGN-PC-0JHFVD binds to FOXP3. ( J ) simvastatin binds to FOXP3. CCL4 is marked in red, FCGR2B in wheat, FOXP3 in green, and candidate drugs in cyan. Blue solid lines represent hydrogen bonds, grey dotted lines represent hydrophobic interactions, and green dotted lines represent π-stacking interactions.

    Journal: Journal of Inflammation Research

    Article Title: Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration

    doi: 10.2147/JIR.S500214

    Figure Lengend Snippet: Molecular docking simulation diagram. ( A ) (+)-chelidonine binds to CCL4. ( B ) oxazolone binds to CCL4. ( C ) eugenol binds to CCL4. ( D ) simvastatin binds to CCL4. ( E ) (+)-chelidonine binds to FCGR2B. ( F ) oxazolone binds to FCGR2B. ( G ) eugenol binds to FCGR2B. ( H ) AGN-PC-0JHFVD binds to FCGR2B. ( I ) AGN-PC-0JHFVD binds to FOXP3. ( J ) simvastatin binds to FOXP3. CCL4 is marked in red, FCGR2B in wheat, FOXP3 in green, and candidate drugs in cyan. Blue solid lines represent hydrogen bonds, grey dotted lines represent hydrophobic interactions, and green dotted lines represent π-stacking interactions.

    Article Snippet: Primary antibodies targeting CCL4 (1:1000, Bioss, bs-2475R, China), FCGR2B (1:1000, Abclonal, A12553, China) and β-actin (1:1000, ZSGB-BIO, TA-09, China) overnight at 4°C.

    Techniques:

    External validation of CCL4 and FCGR2B. ( A ) The mRNA levels of CCL4 and FCGR2B were evaluated in animal models by RT-qPCR. ( B ) The protein levels of CCL4 and FCGR2B were evaluated animal models by WB. ** represents P <0.01, * represents P <0.05 and ns, no significance.

    Journal: Journal of Inflammation Research

    Article Title: Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration

    doi: 10.2147/JIR.S500214

    Figure Lengend Snippet: External validation of CCL4 and FCGR2B. ( A ) The mRNA levels of CCL4 and FCGR2B were evaluated in animal models by RT-qPCR. ( B ) The protein levels of CCL4 and FCGR2B were evaluated animal models by WB. ** represents P <0.01, * represents P <0.05 and ns, no significance.

    Article Snippet: Primary antibodies targeting CCL4 (1:1000, Bioss, bs-2475R, China), FCGR2B (1:1000, Abclonal, A12553, China) and β-actin (1:1000, ZSGB-BIO, TA-09, China) overnight at 4°C.

    Techniques: Quantitative RT-PCR